Medical device industry leaders to meet with lawmakers, government officials at MDMA annual meeting

As the U.S. Food and Drug Administration (FDA) is reviewing pivotal regulatory procedures for one of America's fastest growing sectors, industry leaders will gather to meet with lawmakers and government officials at the 16th Annual Meeting of the Medical Device Manufacturers Association (MDMA) on May 24-26, 2010 at the Park Hyatt in Washington, DC.

Meeting attendees will hear from panels comprised of seasoned experts from Capitol Hill, the FDA and leading manufacturers.  Highlights of the event include a keynote address by FDA Principal Deputy Commissioner Dr. Joshua Sharfstein, as well as a presentation by FDA Director of the Center for Devices and Radiological Health Dr. Jeffrey Shuren.

"The new health care legislation highlighted just how critical it is for manufacturers in our industry to have their voices heard and to get involved in the process," said Joe Kiani, Chairman and CEO of Masimo Corporation. "The MDMA annual meeting will provide vital information on the challenges we face, and how the landscape is shifting for entrepreneurs.  With leading decision makers and elected officials in attendance, this will be a unique opportunity to network with colleagues and learn about tomorrow's changes before they take place, and how our industry can continue to grow."

Medical device manufacturers throughout the country are also analyzing the new tax that will be levied on the industry, and how to lessen its impact before it is imposed in 2013.  The 2010 conference will address this new tax, FDA and patent reform, reimbursement and several other issues that directly affect the medical device industry.

SOURCE Medical Device Manufacturers Association